[go: up one dir, main page]

WO2008034580A3 - Uses of cripowellins and the derivatives thereof for the treatment of tumor diseases - Google Patents

Uses of cripowellins and the derivatives thereof for the treatment of tumor diseases Download PDF

Info

Publication number
WO2008034580A3
WO2008034580A3 PCT/EP2007/008110 EP2007008110W WO2008034580A3 WO 2008034580 A3 WO2008034580 A3 WO 2008034580A3 EP 2007008110 W EP2007008110 W EP 2007008110W WO 2008034580 A3 WO2008034580 A3 WO 2008034580A3
Authority
WO
WIPO (PCT)
Prior art keywords
cripowellins
derivatives
treatment
tumor diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/008110
Other languages
German (de)
French (fr)
Other versions
WO2008034580A2 (en
Inventor
Matthias Gehling
Olaf Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermed Discovery GmbH
Original Assignee
Intermed Discovery GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermed Discovery GmbH filed Critical Intermed Discovery GmbH
Publication of WO2008034580A2 publication Critical patent/WO2008034580A2/en
Publication of WO2008034580A3 publication Critical patent/WO2008034580A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the use of cripowellins and the derivatives thereof for producing medicaments utilized for treating tumor diseases.
PCT/EP2007/008110 2006-09-21 2007-09-17 Uses of cripowellins and the derivatives thereof for the treatment of tumor diseases Ceased WO2008034580A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006045097.3 2006-09-21
DE102006045097A DE102006045097A1 (en) 2006-09-21 2006-09-21 Uses of crypowellins and their derivatives for the treatment of tumor diseases

Publications (2)

Publication Number Publication Date
WO2008034580A2 WO2008034580A2 (en) 2008-03-27
WO2008034580A3 true WO2008034580A3 (en) 2008-08-07

Family

ID=38805797

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/008110 Ceased WO2008034580A2 (en) 2006-09-21 2007-09-17 Uses of cripowellins and the derivatives thereof for the treatment of tumor diseases

Country Status (3)

Country Link
DE (1) DE102006045097A1 (en)
TW (1) TW200827362A (en)
WO (1) WO2008034580A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19610279A1 (en) * 1996-03-15 1997-09-18 Bayer Ag Cripowellins and synthetic derivatives
WO2006136309A1 (en) * 2005-06-23 2006-12-28 Bayer Cropscience Aktiengesellschaft Cripowellins and synthetic derivatives thereof used as medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19610279A1 (en) * 1996-03-15 1997-09-18 Bayer Ag Cripowellins and synthetic derivatives
WO2006136309A1 (en) * 2005-06-23 2006-12-28 Bayer Cropscience Aktiengesellschaft Cripowellins and synthetic derivatives thereof used as medicaments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THI NGOC TRAM N ET AL: "Crinum L. (Amaryllidaceae)", FITOTERAPIA 2002 NL, vol. 73, no. 3, 2002, pages 183 - 208, XP002483781, ISSN: 0367-326X *

Also Published As

Publication number Publication date
DE102006045097A1 (en) 2008-03-27
TW200827362A (en) 2008-07-01
WO2008034580A2 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
MX2009006704A (en) New compounds.
IL192763A (en) Pyrimidine derivatives, compositions comprising them and use thereof for the manufacture of medicaments for the treatment of cancer
WO2004065423A3 (en) Recognition molecules for the treatment and detection of tumours
WO2009050506A3 (en) Combination 059
WO2007150077A8 (en) Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
EP2532673A3 (en) Tubulysine derivatives
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
EP1968607A4 (en) Treatment of cancer and other diseases
ZA200805163B (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer
WO2006058868A3 (en) Substituted pteridines for treating inflammatory diseases
TNSN08400A1 (en) Organic compounds and their uses
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2007135026A3 (en) Substituted pteridines as therapeutic agents
WO2009030224A3 (en) Novel quinazoline compounds and the use thereof for treating cancerous diseases
IL216967B (en) 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives and use thereof for the treatment of diseases
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
MX2010003269A (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase.
WO2009074247A8 (en) Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
WO2010121675A3 (en) Thiazolyl-benzimidazoles
WO2007130501A3 (en) Combination therapy for treatment of cancer
WO2008051421A3 (en) Peptide-cytotoxic conjugates

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07818212

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07818212

Country of ref document: EP

Kind code of ref document: A2